THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 21 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,126,000 | +7.6% | 2,257,000 | 0.0% | 0.00% | – |
| Q3 2020 | $1,975,000 | -9.2% | 2,257,000 | 0.0% | 0.00% | – |
| Q2 2020 | $2,174,000 | +0.3% | 2,257,000 | 0.0% | 0.00% | – |
| Q1 2020 | $2,167,000 | -7.3% | 2,257,000 | 0.0% | 0.00% | – |
| Q4 2019 | $2,338,000 | -56.0% | 2,257,000 | -61.1% | 0.00% | -100.0% |
| Q3 2019 | $5,311,000 | +6.7% | 5,807,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $4,978,000 | -10.6% | 5,807,000 | +1.0% | 0.00% | 0.0% |
| Q1 2019 | $5,569,000 | -5.8% | 5,750,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,915,000 | -12.7% | 5,750,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $6,772,000 | +18.8% | 5,750,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $5,700,000 | -2.0% | 5,750,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,818,000 | -14.7% | 5,750,000 | -8.0% | 0.00% | 0.0% |
| Q4 2017 | $6,824,000 | -10.8% | 6,250,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $7,652,000 | -9.3% | 6,250,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $8,434,000 | +7.0% | 6,250,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $7,883,000 | -0.9% | 6,250,000 | -10.7% | 0.00% | 0.0% |
| Q4 2016 | $7,958,000 | – | 7,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 13,473,000 | $12,756,000 | 1.74% |
| Shaolin Capital Management LLC | 14,065,000 | $13,281,000 | 0.93% |
| ZAZOVE ASSOCIATES LLC | 3,773,000 | $3,584,000 | 0.44% |
| FARALLON CAPITAL MANAGEMENT LLC | 56,695,000 | $53,806,000 | 0.32% |
| Baupost Group | 30,000,000 | $28,396,000 | 0.26% |
| Aequim Alternative Investments LP | 3,000,000 | $2,840,000 | 0.21% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $22,817,000 | 0.17% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $5,257,000 | 0.15% |
| SSI INVESTMENT MANAGEMENT LLC | 1,750,000 | $1,648,000 | 0.12% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 430,000 | $406,000 | 0.06% |